Skip to content

Medical-device intelligence

bioMerieux: FDA clearances and recalls

Research bioMerieux in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

3 clearance records and 17 recall records in the covered releases, across 1 source company names and 9 product codes. Dated history runs from Jul 31, 2003 to Mar 26, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202610
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

20 matching records
Device / recordCompany in FDA recordSourceSource date
VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)K260281 · LONBIOMERIEUX510(k)Mar 26, 2026FDA decision date
Etest Piperacillin/tazobactam (4 ug/mL) PTc0.016-256-pack of 30 tests WW Etest is a quantitative technique for determining the antimicrobial sus…Z-0439-2016 · JWYBiomerieuxRecallDec 23, 2015FDA classification date
Etest PIP/TAZO/CON-4 PTC 256 -pack of 30 tests US. Etest is a quantitative technique for determining the antimicrobial susceptibility of Gram-ne…Z-0440-2016 · JWYBiomerieuxRecallDec 23, 2015FDA classification date
Etest PIP/TAZO/CON-4 PTC 256 - Foam of 100 tests WW. Etest is a quantitative technique for determining the antimicrobial susceptibility of Gram-…Z-0441-2016 · JWYBiomerieuxRecallDec 23, 2015FDA classification date
Etest PIP/TAZO/CON-4 PTC 256 - Foam of 100 tests US. Etest is a quantitative technique for determining the antimicrobial susceptibility of Gram-…Z-0442-2016 · JWYBiomerieuxRecallDec 23, 2015FDA classification date
VIDAS H. pylori IgG, VIDAS 3, VIDAS Lyme IgG II, VIDAS RUB IgG, VIDAS TOXO M, VIDAS Human Chorionic Gonadotropin, VIDAS T4, VIDAS Testosterone, V…K141133 · LYRBIOMERIEUX510(k)Jul 9, 2015FDA decision date
Etest Ceftaroline (CPT32) WW B30. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial sus…Z-0230-2015 · JWYBiomerieuxRecallNov 19, 2014FDA classification date
Etest Ceftaroline (CPT32) WWB100. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial sus…Z-0231-2015 · JWYBiomerieuxRecallNov 19, 2014FDA classification date
Etest Ceftaroline (CPT32) US B30. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial sus…Z-0232-2015 · JWYBiomerieuxRecallNov 19, 2014FDA classification date
Etest Ceftaroline (CPT32) US B100. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial su…Z-0233-2015 · JWYBiomerieuxRecallNov 19, 2014FDA classification date
Etest Ceftaroline (CPT32) US B30. Etest (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial sus…Z-0234-2015 · JWYBiomerieuxRecallNov 19, 2014FDA classification date
ETEST TOBRAMYCIN 0.016-256 UG/ML AND 0.064-1024 UG/MLK102668 · JWYBIOMERIEUX510(k)Nov 17, 2010FDA decision date
BacT/ALERT(BTA) Classic instruments.Z-0456-05 · MDBbioMerieuxRecallFeb 1, 2005FDA classification date
MDA Fibriquik, bioMeriux, Inc., Box 15969, Durham, North Carolina 27704-0969Z-0053-05 · GJAbioMerieuxRecallOct 28, 2004FDA classification date
Fibriquik, bioMeriux, Inc., Box 15969, Durham, North Carolina 27704-0969Z-0054-05 · GJAbioMerieuxRecallOct 28, 2004FDA classification date
The MDA system with MDA Antithrombin III MDA HeparinZ-0043-05 · JPAbioMerieuxRecallOct 23, 2004FDA classification date
VIDAS CMV IgG AssayZ-1047-04 · LFZbioMerieuxRecallJul 20, 2004FDA classification date
VIDAS Chlamydia Assay (CHL) for In-Vitro Diagnostic Use Product Number: 30101Z-1209-03 · LJCbioMerieuxRecallOct 15, 2003FDA classification date
Simplastin L, Prothrombin Time test, 10 vials (20 ml each), Product Number 259553, bioMerieux,Z-1238-03 · GJSbioMerieuxRecallOct 15, 2003FDA classification date
MDA Simplastin L, Product number 252555, 10 vials, 40 ml ea (400 test each), bioMerieux Inc., Box 15969 Durham, North Carolina 27704-0969.Z-1239-03 · GJSbioMerieuxRecallOct 15, 2003FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗